Render Target: STATIC
Render Timestamp: 2024-07-26T10:06:03.296Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

APOBEC3A (E6K2O) Rabbit mAb #56844

Filter:
  • WB

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 23
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    APOBEC3A (E6K2O) Rabbit mAb recognizes endogenous levels of total APOBEC3A protein. This antibody does not cross-react with APOBEC3B or APOBEC3G proteins. Based on the sequence of the immunogenic peptide, this antibody is not expected to detect isoform 2 of APOBEC3A.


    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro9 of human APOBEC3A protein.

    Background

    Members of the APOBEC3 subfamily of cytosine deaminases (APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H) function in innate immunity by preventing viral DNA replication, including that of HIV-1 (1-2). APOBEC3A expression is upregulated in several human cancers, and is a major source of mutation in breast cancer (3). APOBEC3A contributes to chromosomal instability and disease progression in pancreatic cancer (4), and upregulates PD-L1 expression in cancer cells (5).

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.